{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:53:42Z","timestamp":1774896822360,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jbspin.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T20:30:21Z","timestamp":1375907421000},"page":"160-163","source":"Crossref","is-referenced-by-count":11,"title":["Frequency of CYP2C9 polymorphisms in polynesian people and potential relevance to management of gout with benzbromarone"],"prefix":"10.1016","volume":"81","author":[{"given":"Rebecca L.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary C.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.B.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Cadzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2013.07.006_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbspin.2010.02.027","article-title":"The genetic basis of hyperuricaemia and gout","volume":"78","author":"Merriman","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrrheum.2011.207","article-title":"Mechanisms of joint damage in gout: evidence from cellular and imaging studies","volume":"8","author":"McQueen","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0020","article-title":"The experience and impact of gout in Maori and Pacific people: a prospective observational study","author":"Dalbeth","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0025","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00280054","article-title":"Variation of benzbromarone elimination in man\u00a0\u2013\u00a0a population study","volume":"39","author":"Walter-Sack","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1021\/tx7001228","article-title":"Sequential metabolism and bioactivation of the hepatotoxin benzbromarone: formation of glutathione adducts from a catechol intermediate","volume":"20","author":"McDonald","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/pgs.10.49","article-title":"Combined\u00a0CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups","volume":"11","author":"Scott","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2133\/dmpk.DMPK-10-NT-040","article-title":"Benzbromarone pharmacokinetics and pharmacodynamics in different cytochrome P450\u00a02C9 genotypes","volume":"25","author":"Uchida","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0055","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/ar3816","article-title":"The renal urate transporter\u00a0SLC17A1 locus: confirmation of association with gout","volume":"14","author":"Hollis-Moffatt","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA\u00a0sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0065","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/gb-2010-11-8-r86","article-title":"Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences","volume":"11","author":"Goecks","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tox.2009.08.013","article-title":"Polymorphisms of human cytochrome P450\u00a02C9 and the functional relevance","volume":"278","author":"Zhou","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0075","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1124\/mol.107.044149","article-title":"Novel\u00a0CYP2C9 promoter variants and assessment of their impact on gene expression","volume":"73","author":"Kramer","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.2010.03688.x","article-title":"A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients","volume":"70","author":"Lee","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.322","article-title":"The missing association: sequencing-based discovery of novel\u00a0SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans","volume":"89","author":"Perera","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clpt.2005.01.019","article-title":"CYP2C9\u00a0haplotype structure in European American warfarin patients and association with clinical outcomes","volume":"77","author":"Veenstra","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0095","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood-2003-07-2521","article-title":"5\u2032-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients","volume":"103","author":"Takahashi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2013.07.006_bib0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygeno.2010.11.004","article-title":"A systematic genetic polymorphism analysis of the CYP2C9\u00a0gene in four different geographical Han populations in mainland China","volume":"97","author":"Xiong","year":"2011","journal-title":"Genomics"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13001917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13001917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T23:25:33Z","timestamp":1539473133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X13001917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1297319X13001917"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2013.07.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}